About Agios (AGIO)
Agios Pharmaceuticals, Inc is a clinical-stage biopharmaceutical company. The Company's lead product candidate in its genetically defined disease (GDD) portfolio, mitapivat, is an activator for the treatment of hemolytic anemias. The Company’s clinic... Read more
- 29.00
- 30.24
- 28.69
- 36.70
- 0.2%
- 10M
- 660.16k
- 460.60k
- 1.6B
- 16.75
- -21.2%
- %
Stock News
1 hour ago
Earnings Results: Okta CEO promises profit for all of next year — ‘The problem was never that we didn’t have talented sales people’
MarketWatch
1 hour ago
SVB CFO to Participate in Fireside Chat Hosted by Goldman Sachs
Yahoo
1 hour ago
What's Worth Streaming: From ‘Glass Onion’ to ‘1923,’ here’s what’s worth streaming in December 2022
MarketWatch
1 hour ago
The Royals Arrive and 6K CEO Aaron Bent
Bloomberg
More Stock Analysis & Reports
Access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.
